ArticleLeukemia2018

Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma.

P G Richardson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.